Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.

[1]  Vasco Filipe,et al.  Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates , 2010, Pharmaceutical Research.

[2]  C. van Nostrum,et al.  Micelles based on HPMA copolymers. , 2010, Advanced drug delivery reviews.

[3]  K. Ulbrich,et al.  Biological evaluation of polymeric micelles with covalently bound doxorubicin. , 2009, Bioconjugate chemistry.

[4]  K. Kataoka,et al.  Preclinical and clinical studies of anticancer agent‐incorporating polymer micelles , 2009, Cancer science.

[5]  Peter R Seevinck,et al.  Superparamagnetic iron oxide nanoparticles encapsulated in biodegradable thermosensitive polymeric micelles: toward a targeted nanomedicine suitable for image-guided drug delivery. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[6]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[7]  K. Ulbrich,et al.  N-(2-Hydroxypropyl)methacrylamide-Based Polymer Conjugates with pH-Controlled Activation of Doxorubicin. I. New Synthesis, Physicochemical Characterization and Preliminary Biological Evaluation , 2008 .

[8]  T Lammers,et al.  Tumour-targeted nanomedicines: principles and practice , 2008, British Journal of Cancer.

[9]  W. Tsai,et al.  Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  C. van Nostrum,et al.  Photosensitiser-loaded biodegradable polymeric micelles: preparation, characterisation and in vitro PDT efficacy. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[11]  C. van Nostrum,et al.  Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies. , 2007, Biomaterials.

[12]  C. van Nostrum,et al.  Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. , 2007, Journal of Controlled Release.

[13]  H. Kauffmann,et al.  Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin , 2007, Human & experimental toxicology.

[14]  K. Ulbrich,et al.  Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Theresa M. Allen,et al.  Determination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors , 2005, Clinical Cancer Research.

[16]  C. van Nostrum,et al.  Novel fast degradable thermosensitive polymeric micelles based on PEG-block-poly(N-(2-hydroxyethyl)methacrylamide-oligolactates). , 2005, Biomacromolecules.

[17]  Wim E Hennink,et al.  Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[18]  C. van Nostrum,et al.  Physicochemical characterization of degradable thermosensitive polymeric micelles. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[19]  C. van Nostrum,et al.  The effect of the processing and formulation parameters on the size of nanoparticles based on block copolymers of poly(ethylene glycol) and poly(N-isopropylacrylamide) with and without hydrolytically sensitive groups. , 2004, Biomaterials.

[20]  W. Hennink,et al.  Degradation Mechanism and Kinetics of Thermosensitive Polyacrylamides Containing Lactic Acid Side Chains , 2003 .

[21]  R. Duncan.  The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[22]  K. Ulbrich,et al.  HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[23]  K. Ulbrich,et al.  Differences in the intracellular fate of free and polymer-bound doxorubicin. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[24]  K. Ulbrich,et al.  HPMA-hydrogels result in prolonged delivery of anticancer drugs and are a promising tool for the treatment of sensitive and multidrug resistant leukaemia. , 2002, European journal of cancer.

[25]  K. Ulbrich,et al.  New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[26]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[27]  M. Hasegawa,et al.  Comparison of effects of doxorubicin and radiation on p53-dependent apoptosis in vivo. , 2000, Oncology reports.

[28]  T. Okano,et al.  Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[29]  D. Papahadjopoulos,et al.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.

[30]  W. Hennink,et al.  Cationic polymeric gene delivery of β‐glucuronidase for doxorubicin prodrug therapy , 1999, The journal of gene medicine.

[31]  W. Hennink,et al.  Degradation kinetics of methacrylated dextrans in aqueous solution. , 1997, Journal of pharmaceutical sciences.

[32]  C. Kurahara,et al.  Prevention of doxorubicin-induced hematotoxicity in mice by interleukin 1. , 1989, Cancer research.

[33]  S. Siegel,et al.  Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells. , 1976, Cancer research.

[34]  K. Ulbrich,et al.  Preclinical Evaluation of Linear HPMA-Doxorubicin Conjugates with pH-Sensitive Drug Release: Efficacy, Safety, and Immunomodulating Activity in Murine Model , 2009, Pharmaceutical Research.

[35]  W. Hennink,et al.  Polymeric micelles with transient stability : A novel delivery concept , 2006 .

[36]  V. Torchilin,et al.  Drug targeting. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[37]  I. Mellman.  Endocytosis and molecular sorting. , 1996, Annual review of cell and developmental biology.